SEC approval for Bharat Biotech’s COVID booster intranasal vaccine phase 3 trials

The SEC has asked the Hyderabad-based vaccine manufacturer to submit its revised protocol for trials

This post was originally published on The Asian Age | Home.

Print Share Comment Cite Upload Translate Updates

APA

The Asian Age | Home | radiofree.asia (2024-05-18T18:31:33+00:00) » SEC approval for Bharat Biotech’s COVID booster intranasal vaccine phase 3 trials. Retrieved from https://radiofree.asia/2022/01/05/sec-approval-for-bharat-biotechs-covid-booster-intranasal-vaccine-phase-3-trials/.

MLA

" » SEC approval for Bharat Biotech’s COVID booster intranasal vaccine phase 3 trials." The Asian Age | Home | radiofree.asia - Wednesday January 5, 2022, https://radiofree.asia/2022/01/05/sec-approval-for-bharat-biotechs-covid-booster-intranasal-vaccine-phase-3-trials/

HARVARD

The Asian Age | Home | radiofree.asia Wednesday January 5, 2022 » SEC approval for Bharat Biotech’s COVID booster intranasal vaccine phase 3 trials., viewed 2024-05-18T18:31:33+00:00,<https://radiofree.asia/2022/01/05/sec-approval-for-bharat-biotechs-covid-booster-intranasal-vaccine-phase-3-trials/>

VANCOUVER

The Asian Age | Home | radiofree.asia - » SEC approval for Bharat Biotech’s COVID booster intranasal vaccine phase 3 trials. [Internet]. [Accessed 2024-05-18T18:31:33+00:00]. Available from: https://radiofree.asia/2022/01/05/sec-approval-for-bharat-biotechs-covid-booster-intranasal-vaccine-phase-3-trials/

CHICAGO

" » SEC approval for Bharat Biotech’s COVID booster intranasal vaccine phase 3 trials." The Asian Age | Home | radiofree.asia - Accessed 2024-05-18T18:31:33+00:00. https://radiofree.asia/2022/01/05/sec-approval-for-bharat-biotechs-covid-booster-intranasal-vaccine-phase-3-trials/

IEEE

" » SEC approval for Bharat Biotech’s COVID booster intranasal vaccine phase 3 trials." The Asian Age | Home | radiofree.asia [Online]. Available: https://radiofree.asia/2022/01/05/sec-approval-for-bharat-biotechs-covid-booster-intranasal-vaccine-phase-3-trials/. [Accessed: 2024-05-18T18:31:33+00:00]

rf:citation

» SEC approval for Bharat Biotech’s COVID booster intranasal vaccine phase 3 trials | The Asian Age | Home | radiofree.asia | https://radiofree.asia/2022/01/05/sec-approval-for-bharat-biotechs-covid-booster-intranasal-vaccine-phase-3-trials/ | 2024-05-18T18:31:33+00:00

To access this feature and upload your own media, you must Login or create an account.

Add an image

Choose a Language

A Free News Initiative